Claritev Corporation

Claritev Corporation

CTEV

Get informed when a big investor buys or sells

+ Follow
Market Cap$635.37M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Claritev CorporationClaritev Corporation-2.2-96%0.6-15.7
$50.80

Target Price by Analysts

35% upsideClaritev Target Price DetailsTarget Price
$-48.24

Current Fair Value

228.2% downside

Overvalued by 228.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$635.37 Million
Enterprise Value$5.24 Billion
Dividend Yield$- (-)
Earnings per Share$-17.3
Beta0.79
Outstanding Shares16,964,960

Return

Return on Equity96.11%ROE
Return on Assets-5.94%
Return on Invested Capital0.70%

Valuation & Multiples

P/E Ratio-2.19P/E Ratio
PEG40.2PEG
Price to Sales0.65Price to Sales
Price to Book Ratio-2.21Price to Book Ratio
Enterprise Value to Revenue5.27
Enterprise Value to EBIT164.56
Enterprise Value to Net Income-19
Total Debt to Enterprise0.88
Debt to Equity-15.69Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 7, 2026
EPS Estimate
$-4.12
Average shareholder expectation
Revenue Estimate
$244.81 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 6, 2026
EPS Estimate
$-3.63
Average shareholder expectation
Revenue Estimate
$256.46 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5436 25.54%
Total Calls67,700 34.53%
Total Puts36,800 23.49%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %86.12% 0.38%
Total Invested$231.48M 61.58%
Investors Holding99 11.00%

ESG Score

No data

About Claritev Corporation

2,700 employees
CEO: Mr. Travis S. Dalton

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...